GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Accounts Receivable

CompuGroup Medical SE KgaA (XTER:COP) Accounts Receivable : €216 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. CompuGroup Medical SE KgaA's accounts receivables for the quarter that ended in Mar. 2024 was €216 Mil.

Accounts receivable can be measured by Days Sales Outstanding. CompuGroup Medical SE KgaA's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 69.30.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. CompuGroup Medical SE KgaA's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was €-19.64.


CompuGroup Medical SE KgaA Accounts Receivable Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Accounts Receivable Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102.98 137.20 147.23 189.44 175.46

CompuGroup Medical SE KgaA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.65 175.28 176.51 175.46 216.16

CompuGroup Medical SE KgaA Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


CompuGroup Medical SE KgaA Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

CompuGroup Medical SE KgaA's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=216.162/284.624*91
=69.30

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), CompuGroup Medical SE KgaA's accounts receivable are only considered to be worth 75% of book value:

CompuGroup Medical SE KgaA's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(123.599+0.75 * 216.162+0.5 * 16.763-1316.889
-0-1.467)/52.159
=-19.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


CompuGroup Medical SE KgaA Accounts Receivable Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA (XTER:COP) Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.
Executives
Michael Rauch Managing director of the general partner of the issuer
Emanuele Mugnani Managing director of the general partner of the issuer
Frank Gotthardt Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl Managing director of the general partner of the issuer
Dr. Eckart Pech Managing director of the general partner of the issuer
Dr. Dirk Wössner CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen Managing director of the general partner of the issuer

CompuGroup Medical SE KgaA (XTER:COP) Headlines

From GuruFocus

Q3 2021 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Conocophillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Conocophillips Analyst & Investor Meeting Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q2 2020 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024

Q2 2021 ConocoPhillips Earnings Call Transcript

By GuruFocus Research 01-22-2024

ConocoPhillips Market Update Conference Call Transcript

By GuruFocus Research 01-22-2024